Evidence map›Paper›PMID 27911767›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2016

Phosphatidylinositol 3-kinase inhibition restores Ca2+ release defects and prolongs survival in myotubularin-deficient mice.

Candice Kutchukian, Mirella Lo Scrudato, Yves Tourneur, Karine Poulard, Alban Vignaud, Christine Berthier, Bruno Allard, Michael W Lawlor, Ana Buj-Bello, Vincent Jacquemond

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. In vivo RyR1 reduction in muscle triggers a core-like myopathy.Acta neuropathologica communications · 2020
    Article
  17. The intragenic microRNAThe Journal of biological chemistry · 2020
    Article
  18. AAV-Mediated Gene Transfer Restores a Normal Muscle Transcriptome in a Canine Model of X-Linked Myotubular Myopathy.Molecular therapy : the journal of the American Society of Gene Therapy · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Candice KutchukianInstitut NeuroMyoGène, CNRS UMR 5310, INSERM U1217, Université Claude Bernard Lyon 1, F69622 Villeurbanne, France.
Mirella Lo ScrudatoGénéthon, 91002 Evry, France.
Yves TourneurFaculté de Médecine Lyon Sud, Cardiovasculaire, Métabolisme, Diabétologie et Nutrition, INSERM U1060, 69921 Oullins, France.
Karine PoulardGénéthon, 91002 Evry, France.
Alban VignaudGénéthon, 91002 Evry, France.
Christine BerthierInstitut NeuroMyoGène, CNRS UMR 5310, INSERM U1217, Université Claude Bernard Lyon 1, F69622 Villeurbanne, France.
Bruno AllardInstitut NeuroMyoGène, CNRS UMR 5310, INSERM U1217, Université Claude Bernard Lyon 1, F69622 Villeurbanne, France.
Michael W LawlorDivision of Pediatric Pathology, Department of Pathology and Laboratory Medicine, Medical College of Wisconsin, Milwaukee, WI 53226.
Ana Buj-BelloGénéthon, 91002 Evry, France.
Vincent JacquemondInstitut NeuroMyoGène, CNRS UMR 5310, INSERM U1217, Université Claude Bernard Lyon 1, F69622 Villeurbanne, France; vincent.jacquemond@univ-lyon1.fr.
Inserm · FRGenethon (France) · FRCentre National de la Recherche Scientifique · FRInstitut NeuroMyoGène · FRMedical College of Wisconsin · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in the gene encoding the phosphoinositide 3-phosphatase myotubularin (MTM1) are responsible for a pediatric disease of skeletal muscle named myotubular myopathy (XLMTM). Muscle fibers from MTM1-deficient mice present defects in excitation-contraction (EC) coupling likely responsible for the disease-associated fatal muscle weakness. However, the mechanism leading to EC coupling failure remains unclear. During normal skeletal muscle EC coupling, transverse (t) tubule depolarization triggers sarcoplasmic reticulum (SR) Ca

Indexed as

Phosphoinositide-3 Kinase InhibitorsAndrostadienesAnimalsCalcium SignalingDisease Models, AnimalEnzyme InhibitorsExcitation Contraction CouplingIn Vitro TechniquesMaleMiceMice, 129 StrainMice, KnockoutMuscle Fibers, SkeletalMyopathies, Structural, CongenitalPatch-Clamp TechniquesProtein Tyrosine Phosphatases, Non-ReceptorAndrostadienesEnzyme InhibitorsmyotubularinPhosphoinositide-3 Kinase InhibitorsProtein Tyrosine Phosphatases, Non-ReceptorWortmanninexcitation–contraction couplingmyotubularinryanodine receptorsarcoplasmic reticulum Ca2+ releaseskeletal muscle

Identifiers

PMID27911767
PMCPMC5167204
OpenAlexW2558016510

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.